Literature DB >> 22019427

The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2.

Kyung D Moon1, Xiaoying Zhang, Qing Zhou, Robert L Geahlen.   

Abstract

Syk is a 72-kDa protein-tyrosine kinase that regulates signaling through multiple cell surface receptors including those for antigens, immunoglobulins and proteins of the extracellular matrix. As part of its function, Syk binds a variety of downstream effectors through interactions that are often mediated by motifs that recognize phosphotyrosines. In a search for novel Syk-interacting proteins by yeast two-hybrid analysis, we identified tensin2 as a Syk-binding protein. Syk interacts with a fragment of tensin2 located near the C-terminus that contains SH2 and PTB domains. In epithelial cells, tensin2 localizes both to focal adhesions and to large cytoplasmic puncta. It is within these punctuate structures that Syk and tensin2 are co-localized. The clustering of Syk within these structures leads to its phosphorylation on tyrosine.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019427      PMCID: PMC3273629          DOI: 10.1016/j.bbamcr.2011.10.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

1.  Gas6/Axl signaling activates the phosphatidylinositol 3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis.

Authors:  Sai Latha Shankar; Kathleen O'Guin; Mimi Kim; Brian Varnum; Greg Lemke; Celia F Brosnan; Bridget Shafit-Zagardo
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

2.  Structure of the PTB domain of tensin1 and a model for its recruitment to fibrillar adhesions.

Authors:  Clare J McCleverty; Diane C Lin; Robert C Liddington
Journal:  Protein Sci       Date:  2007-05-01       Impact factor: 6.725

3.  Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.

Authors:  Judy Wai Ping Yam; Frankie Chi Fat Ko; Chung-Yiu Chan; Dong-Yan Jin; Irene Oi-Lin Ng
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

4.  Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.

Authors:  Xiaoying Zhang; Ulka Shrikhande; Bethany M Alicie; Qing Zhou; Robert L Geahlen
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

5.  Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.

Authors:  Xiaolan Qian; Guorong Li; Holly K Asmussen; Laura Asnaghi; William C Vass; Richard Braverman; Kenneth M Yamada; Nicholas C Popescu; Alex G Papageorge; Douglas R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

Review 6.  Syk and pTyr'd: Signaling through the B cell antigen receptor.

Authors:  Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2009-03-21

7.  The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.

Authors:  Yi-Chun Liao; Lizhen Si; Ralph W deVere White; Su Hao Lo
Journal:  J Cell Biol       Date:  2006-12-26       Impact factor: 10.539

8.  The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.

Authors:  Q Zhou; R L Geahlen
Journal:  Oncogene       Date:  2009-01-19       Impact factor: 9.867

9.  Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.

Authors:  Lo-Kong Chan; Frankie Chi Fat Ko; Irene Oi-Lin Ng; Judy Wai Ping Yam
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

10.  Syk-mediated translocation of PI3Kdelta to the leading edge controls lamellipodium formation and migration of leukocytes.

Authors:  Jürgen Schymeinsky; Cornelia Then; Anca Sindrilaru; Ronald Gerstl; Zoltán Jakus; Victor L J Tybulewicz; Karin Scharffetter-Kochanek; Barbara Walzog
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more
  5 in total

1.  Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.

Authors:  So-Hyun Shin; Kwang Ho Lee; Baek-Hee Kim; Sun Lee; Hwan Seok Lee; Ja-June Jang; Gyeong Hoon Kang
Journal:  Lab Invest       Date:  2014-10-13       Impact factor: 5.662

2.  Cellular phosphatase activity of C1-Ten/Tensin2 is controlled by Phosphatidylinositol-3,4,5-triphosphate binding through the C1-Ten/Tensin2 SH2 domain.

Authors:  Eui Kim; Do-Hyeon Kim; Indira Singaram; Heeyoon Jeong; Ara Koh; Jiyoun Lee; Wonhwa Cho; Sung Ho Ryu
Journal:  Cell Signal       Date:  2018-08-07       Impact factor: 4.315

3.  Deletion of the Tensin2 SH2-PTB domain, but not the loss of its PTPase activity, induces podocyte injury in FVB/N mouse strain.

Authors:  Hayato Sasaki; Yuki Takahashi; Tsubasa Ogawa; Koki Hiura; Kenta Nakano; Makoto Sugiyama; Tadashi Okamura; Nobuya Sasaki
Journal:  Exp Anim       Date:  2019-11-12

4.  AXL phosphorylates and up-regulates TNS2 and its implications in IRS-1-associated metabolism in cancer cells.

Authors:  Li-Chun Cheng; Yen-Lin Chen; An-Ning Cheng; Alan Yueh-Luen Lee; Chun-Yu Cho; Jhy-Shrian Huang; Shuang-En Chuang
Journal:  J Biomed Sci       Date:  2018-11-12       Impact factor: 8.410

5.  Down-regulation of tensin2 enhances tumorigenicity and is associated with a variety of cancers.

Authors:  Shiao-Ya Hong; Yi-Ping Shih; Peng Sun; Wang-Ju Hsieh; Wen-Chang Lin; Su Hao Lo
Journal:  Oncotarget       Date:  2016-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.